Ronald Reagan was in love with America, 'Reagan' co-star Nick Searcy says
Virtual Reality in Tourism Market to Witness Stunning Growth with Airbnb, Google, Sony PlayStation VRThe shocking murder of Dr. Shriram Singh, a respected Indian academic and entrepreneur in the United States, has left his family and community in deep mourning. The 58-year-old, originally from Gonda, Uttar Pradesh, was shot dead in a brutal attack while driving in Atlanta, Georgia, on Wednesday. Dr. Singh had lived in the United States for nearly four decades, contributing both to academia and business. He initially moved to the US in 1990 to take up a position as a professor at Atlanta Agricultural University. His dedication to education and his social charisma quickly earned him respect within his community. After years of academic work, Dr. Singh transitioned into business, founding a series of successful ventures. He expanded his reach by partnering with businessmen of Indian (Punjab and Gujarat) and Pakistani origin, venturing into diverse sectors such as shopping malls, petrol stations, and hotels. His entrepreneurial journey was marked by rapid success, but it also attracted the envy of rivals. Dr. Singh’s younger brother, Shivaji Singh, believes business competition may have played a role in his brother’s untimely death. According to Shivaji, Dr. Singh’s businesses had grown quickly, and his expanding influence in the market, especially in the US, may have led to conflicts with business rivals. These tensions could have been a motive for the attack. As Dr. Singh’s business empire flourished, he built connections with a wide range of entrepreneurs, further increasing his visibility. His brother shared that recently, some businessmen of Pakistani origin also became involved in his ventures, which might have heightened tensions in certain circles. Beyond his professional success, Dr. Singh was known for his strong family values. His sons, Amit and Ankur Singh, have achieved great success in their respective fields. Amit is an engineer with the FBI, while Ankur is a cancer specialist in the US. Dr. Singh’s family remembers him as a kind, social individual who stayed connected with his roots. He frequently visited his village, Tulsipur Majha, in Uttar Pradesh, where he was warmly received by villagers. In fact, he had planned to visit his hometown again in March 2025, just a few months after his tragic death. The people of Tulsipur Majha are devastated by the loss of a beloved figure. Village head Lalji Singh expressed the community’s sorrow, calling for a thorough investigation into the murder. Villagers are also seeking protection for Dr. Singh’s family and justice for the perpetrator(s). Dr. Singh’s tragic death has not only shocked his family and friends but also highlighted the growing challenges faced by Indian professionals living abroad. His success story, marked by academic achievements and entrepreneurial ambition, came to an abrupt and violent end. As authorities work to uncover the motive behind this shocking crime, the community remains hopeful for swift justice.
, /PRNewswire/ -- Tomorrow, AT&T's chief executive officer will participate in a fireside chat where he will discuss the Company's multi-year strategic growth plan. : , chief executive officer, ( ), will speak tomorrow at the UBS Global Media & Communications Conference where he will provide an update to shareholders. Stankey is expected to cover key topics discussed below. As a result of the investment-led strategy announced at its , the Company expects to be in a differentiated position within the connectivity industry by the end of the decade. In Mobility, the Company is building a more efficient, high-capacity, programmable and open network. By 2027, it expects to have largely completed the modernization of its 5G wireless network with open technology, with deep mid-band 5G spectrum covering 300 million+ people by the end of 2026. In broadband, the Company already has the largest fiber broadband network in America. By the end of 2029, it expects to reach 50 million+ total locations with fiber . This includes expectations to pass about 45 million locations through its organic fiber deployment and to serve 5 million+ fiber locations through Gigapower, its joint venture with Blackrock, as well as through agreements with commercial open-access providers. These collective efforts increase AT&T's opportunity to serve customers how they want to be served, by one provider in a converged manner. While building the network of the future, the Company is actively working to exit its legacy copper network operations across the large majority of its wireline footprint by the end of 2029. As discussed during the Company's 2024 Analyst & Investor Day, it expects 2025 Free Cash Flow of $16 billion+, when excluding DIRECTV. The expected drivers of next year's free cash flow growth include Adjusted EBITDA growth, lower cash interest from lower debt balances, the absence of network termination fee payments in 2025 and lower working capital impacts in 2025 compared to 2024. These items are expected to more than offset an expected increase in cash taxes. AT&T expects its multi-year strategic plan to provide $50 billion+ of financial capacity over the next three years, largely through organic growth. Financial capacity represents anticipated free cash flow after distributions to noncontrolling interests, plus expected cash payments from the announced agreement to sell AT&T's stake in DIRECTV to TPG, as well as net borrowing capacity after the Company achieves its net leverage target. The Company continues to expect to achieve its net leverage target of net-debt-to-adjusted EBITDA in the 2.5x range in the first half of 2025 and maintain leverage within this range through 2027. The Company expects to return $40 billion+ of this financial capacity to shareholders through dividends and share repurchases. Under this capital return plan, the Company expects to maintain its current annualized common stock dividend of per share. This plan would result in $20 billion+ in total dividend payments, with capacity for about in share repurchases, from 2025-2027. The plan also contemplates approximately in incremental financial flexibility for items such as potential organic or inorganic strategic growth investments, debt repayment, redemptions of noncontrolling interests, or additional dividends or share repurchases. Tune in for the fireside chat with at the UBS Global Media & Communications Conference, scheduled to begin at . The webcast will be available live and for replay at To automatically receive AT&T financial news by email, please "Total locations" includes consumer and business locations (i) passed with fiber and (ii) served with fiber through commercial open-access providers. Information set forth in this news release contains financial estimates and other forward-looking statements that are subject to risks and uncertainties, and actual results might differ materially. A discussion of factors that may affect future results is contained in AT&T's filings with the Securities and Exchange Commission. AT&T disclaims any obligation to update and revise statements contained in this news release based on new information or otherwise. This news release may contain certain non-GAAP financial measures. Reconciliations between the non-GAAP financial measures and the GAAP financial measures are available on the company's website at . We help more than 100 million U.S. families, friends and neighbors, plus nearly 2.5 million businesses, connect to greater possibility. From the first phone call 140+ years ago to our 5G wireless and multi-gig internet offerings today, we @ATT innovate to improve lives. For more information about AT&T Inc. ( ), please visit us at . Investors can learn more at . © 2024 AT&T Intellectual Property. All rights reserved. AT&T and the Globe logo are registered trademarks of AT&T Intellectual Property. View original content to download multimedia: SOURCE AT&T
New collagen-based dermal matrix designed for tissue generation, complementary to RECELL and PermeaDerm Cohealyx expected to triple AVITA Medical's addressable market in burns VALENCIA, Calif., Dec. 19, 2024 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. RCEL AVH ), a commercial-stage regenerative medicine company focused on first-in-class devices for wound care management and skin restoration, today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for Cohealyx TM , a new collagen-based dermal matrix branded by AVITA Medical and co-developed with Regenity Biosciences. Cohealyx is designed for tissue integration and revascularization to facilitate wound healing, reduce treatment timelines, and improve patient outcomes in the treatment of full-thickness wounds. Burns and full-thickness wounds penetrate all layers of the skin, resulting in significant tissue loss and structural damage. Unlike superficial wounds, full-thickness wounds lack the cellular components and structural support necessary to regenerate missing tissue. Without timely surgical intervention, there is heightened risk of delayed closure, infection, and severe scarring. Dermal matrices are essential in two-stage procedures for treating these wounds, as they support tissue generation for successful skin graft take and improve healing outcomes. Cohealyx addresses this critical need in the treatment of full-thickness wounds with an advanced bovine collagen-based design engineered to facilitate cellular migration and blood vessel formation. Preclinical studies in porcine models demonstrated that Cohealyx generated robust tissue capable of consistently supporting a split-thickness skin graft in a two-stage procedure earlier than leading dermal matrices in the study. While animal model results do not necessarily translate to clinical results, this expedited timeline is anticipated to lead to quicker wound closure and streamlined clinician workflows, resulting in shorter hospital stays, reduced treatment costs, and better patient outcomes. These parameters will be evaluated in a clinical study. "Cohealyx is a strategic addition to our RECELL-centric portfolio, unlocking the powerful synergies of RECELL and Cohealyx to address full-thickness wounds," said Jim Corbett, Chief Executive Officer of AVITA Medical. "This expansion to our product portfolio strengthens our ability to deliver superior patient outcomes and significantly expands our commercial potential in burns. By equipping clinicians with more comprehensive treatment options, we strengthen our competitive position, drive new growth opportunities, and further our commitment to advancing regenerative medicine." Cohealyx strengthens AVITA Medical's portfolio by expanding its capabilities in the treatment of full-thickness wounds. Offered alongside RECELL and PermeaDerm ® , Cohealyx enhances our comprehensive portfolio for addressing full-thickness wound care. This expanded portfolio is expected to triple AVITA Medical's addressable market in burns, as dermal matrices are a critical component of the standard two-stage surgical procedure for definitive closure of these wounds. We also anticipate Cohealyx will generate significant revenue as we penetrate the full-thickness skin defect market. AVITA Medical plans to develop clinical data for Cohealyx in early 2025 to build on the preclinical success and support the product's commercial launch. The post-market clinical study will assess Cohealyx's performance in real-world settings, focusing on clinical efficacy and cost savings in the treatment of full-thickness wounds and burns. In the U.S., we expect to launch full commercialization efforts in the beginning of the second quarter of 2025. About AVITA Medical, Inc. AVITA Medical is a commercial-stage regenerative medicine company transforming the standard of care in wound care management and skin restoration with innovative devices. At the forefront of our platform is the RECELL System, approved by the FDA for the treatment of thermal burn wounds and full-thickness skin defects, and for repigmentation of stable depigmented vitiligo lesions. RECELL harnesses the regenerative properties of a patient's own skin to create Spray-On Skin TM Cells, delivering a transformative solution at the point-of-care. This breakthrough technology serves as the catalyst for a new treatment paradigm enabling improved clinical outcomes. In the United States, AVITA Medical also holds the exclusive rights to market, sell, and distribute PermeaDerm, a biosynthetic wound matrix, and Cohealyx, an AVITA Medical-branded collagen-based dermal matrix. In international markets, the RECELL System is approved to promote skin healing in a wide range of applications including burns, full-thickness skin defects, and vitiligo. The RECELL System, excluding RECELL GO TM , is TGA-registered in Australia, has received CE mark approval in Europe, and has PMDA approval in Japan. To learn more, visit www.avitamedical.com . About Regenity Biosciences Regenity Biosciences, a Linden Capital Partners portfolio company, is a leading global developer and manufacturer of bioresorbable technologies to repair and regenerate natural tissue and bone for a variety of markets including dental, spine, orthopaedic, sports medicine, advanced wound, neurosurgery, ENT, and nerve repair. Founded in 1997, Regenity (formerly Collagen Matrix, Inc.) is headquartered in Paramus, New Jersey, with manufacturing locations in Oakland and Allendale, New Jersey and Groningen, the Netherlands. Regenity's product portfolio includes a variety of collagen-based and synthetic polymer solutions that support the company's platform for tissue and bone regeneration. Regenity develops proprietary products that are sold to OEM customers on either a contract or private label basis and offers partnership opportunities including contract product development and manufacturing services. For more information, please visit www.regenity.com . Forward-Looking Statements Th is press release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements are subject to significant risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. Forward-looking statements generally may be identified by the use of words such as "anticipate," "expect," "intend," "could," "would," "may," "will," "believe," "continue," "estimate," "look forward," "forecast," "goal," "target," "project," "outlook," "guidance," "future," and similar words or expressions, and the use of future dates. Forward-looking statements include, but are not limited to, statements relating to the timing and realization of regulatory approvals of our products; physician acceptance, endorsement, and use of our products; anticipated market share growth and revenue generation from certain products; failure to achieve the anticipated benefits from approval of our products; the effect of regulatory actions; product liability claims; risks associated with international operations and expansion; and other business effects, including the effects of industry, as well as other economic or political conditions outside of the Company's control. These statements are made as of the date of this release, and the Company undertakes no obligation to publicly update or revise any of these statements, except as required by law. For additional information and other important factors that may cause actual results to differ materially from forward-looking statements, please see the "Risk Factors" section of the Company's latest Annual Report on Form 10-K and other publicly available filings for a discussion of these and other risks and uncertainties. Authorized for release by the Chief Financial Officer of AVITA Medical, Inc. © 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.Ormat Announces Public Offering of Common Stock on Behalf of Stockholder ORIX Corporation
Met Éireann forecasts wet and windy conditions ahead of New Year’s EveArcher Aviation (NYSE:ACHR) Stock Price Up 1.3% – Should You Buy?Trump has flip-flopped on abortion policy. His appointees may offer clues to what happens next
None
Mattr Corp. Announces Closing of Debt Subscription Receipt Offering
CRM Lead Management Market is Booming Worldwide | Big Giants Salesforce, HubSpot, Microsoft DynamicsBig Ten After Dark is probably a suitable stage for the 5-5 Trojans and 4-6 Bruins on Saturday night from the Rose Bowl
Asbestos Testing Market Size & Share, Analysis 2031Poulin has game winner as Montreal Victoire tops Minnesota Frost 3-2 for 3rd straight win SAINT PAUL, Minn. (AP) — Mariah Keopple and Alexandra Labelle scored their first goals of the season and the Montreal Victoire edged the Minnesota Frost 3-2 on Saturday. Canadian Press Dec 28, 2024 2:32 PM Dec 28, 2024 2:35 PM Share by Email Share on Facebook Share on X Share on LinkedIn Print Share via Text Message SAINT PAUL, Minn. (AP) — Mariah Keopple and Alexandra Labelle scored their first goals of the season and the Montreal Victoire edged the Minnesota Frost 3-2 on Saturday. Marie-Philip Poulin's goal almost six minutes into the second period was the difference as she converted a 2-on-1 from Laura Stacey and Jennifer Gardiner and Montreal (2-2-0-1), which went 0 for 3 on the power play, won its third straight while handing Minnesota (3-1-1-1) its first regulation loss of the season. Despite having the better control of the action from the start Montreal fell behind 1-0 near the middle of the first period when Claire Thompson and Taylor Heise set up Britta Curl-Salemme for her third goal of the season. But in the last five minutes of the period Keopple scored on a pass from Claire Dalton, and Labelle banged in a rebound of her initial shot. Minnesota pulled into a tie at just 3:17 into the second period when Brooke McQuigge picked up her first goal during a scramble in front of the Montreal goal. Barely 2 1/2 minutes later the Victoire were back on top on Poulin's second goal of the season and Ann-Renee Desbiens, who made 22 saves, made that stand up. Maddie Rooney made 22 saves for Minnesota, which went 0-1 on the power play. Boston plays at Montreal on Monday. The Frost are home against Boston on Thursday. ___ AP women’s hockey: https://apnews.com/hub/womens-hockey The Associated Press See a typo/mistake? Have a story/tip? This has been shared 0 times 0 Shares Share by Email Share on Facebook Share on X Share on LinkedIn Print Share via Text Message More National Sports 'Let's not panic': Canada picks up the pieces after ugly Latvia loss at world juniors Dec 28, 2024 2:08 PM Dobes gets shutout in NHL debut, Canadiens blank Panthers 4-0 Dec 28, 2024 1:24 PM Quinn Hughes and Elias Pettersson out for Canucks vs. Kraken Dec 28, 2024 12:31 PM Featured FlyerDemocrats under fire for ‘excusing’ murder of UnitedHealthcare CEO
Many took to social media over the past few days to mourn Matt Verde, Oswego resident and restaurant owner, who died on Sunday after he was struck by a vehicle days earlier. Verde owned Neat Kitchen + Bar, which has locations in both Oswego and Westmont. In a Facebook post, Westmont Chamber of Commerce and Tourism Bureau Board Chair Becky Rheintgen said his death leaves behind “a deep void in the hearts of his family, friends and everyone who had the privilege of knowing him. “Matt was more than a business owner — he was a core part of our business community, a passionate entrepreneur and a generous supporter of local initiatives,” Rheintgen said in the post. “Through Neat Kitchen + Bar, he brought people together, fostering a sense of community and creating a warm and welcoming space where countless memories were made.” According to the Oswego Police Department, Verde was attempting to walk across an access road in the shopping center at 2700 Route 34 on Nov. 21 at around 9:40 p.m. when he was hit by a car. Preliminary investigations indicated that a 17-year-old girl was driving southbound on the access road between the Meijer parking lot and the stores in the 1400 block of Douglas Road when she struck Verde, who was crossing the access road westbound, police said. According to the police’s news release, a witness reported seeing a man wearing dark clothing heading diagonally through the parking lot shortly before the crash. No charges have been filed, and the crash is still under investigation, officials said. The girl was not injured in the crash, but it left Verde with serious, life-threatening injuries, which he succumbed to on Sunday, police said. A GoFundMe campaign was set up over the weekend to support Verde. Now, those proceeds are set to go to his family for upcoming arrangements and expenses, according to an update on the fundraiser’s webpage. The campaign was set up by Carrie and Steve Fleck, owners of Dolce Restaurant and Wine Bar in Westmont, after “the request of so many and with the approval from the family,” the two wrote on the campaign’s webpage. As of Tuesday afternoon, the campaign had raised $73,664, surpassing its $50,000 goal with 665 donations. In an update to both the GoFundMe campaign webpage and the restaurant’s Facebook page, the Flecks said that they “are devastated by this ending but know that Matt’s work is not done as he watches over all of us from heaven.” Other local restaurants also remembered Verde in their own Facebook posts. Hinsdale Wine Shop said on its page that Verde was more than just a local business owner, he was also a friend and a “beacon of kindness in our community.” “Matt was a kind, compassionate and genuine man who treated everyone with respect and warmth,” Hinsdale Wine Shop’s post said. Candace Buchanan, owner of Mrs. T’s Pizza, said on the restaurant’s Facebook page that she is “heartbroken and speechless.” Verde would always go out of his way to make her feel welcome after her business opened just over a year ago, she said. “Matt was always thinking about what he could do to help the next person. I am deeply sorry for the loss of a good friend,” Buchanan said in the Facebook post. On the GoFundMe campaign page, the Flecks asked people to continue to support both Neat Kitchen + Bar locations so the family can continue to have income. Both restaurants are set to stay open, Cindy Maquet of Neat Kitchen + Bar told The Beacon News in an email. That is what Verde would have wanted, so the Neat team, which is like a family, will “continue his legacy and the success of both restaurants,” she said. “Matt was truly an incredible person and his presence will be deeply missed by everyone who knew him,” Maquet said. rsmith@chicagotribune.com
By Maayan Lubell and Nidal al-Mughrabi JERUSALEM/CAIRO (Reuters) - Israelis and Palestinians are signaling new efforts to forge a ceasefire deal, even a limited one, for the first time in a year that would pause the fighting in Gaza and return to Israel some of the hostages still held in the Palestinian enclave. Israel Defence Minister Israel Katz told his U.S. counterpart Lloyd Austin in a phone call on Wednesday there was now a chance for a new deal that would allow the return of all the hostages, including U.S. citizens, Katz's office said. A Western diplomat in the region, however, said a deal was taking shape, but it would likely be limited in scope, involving the release of only a handful of hostages and a short pause in hostilities. Such a truce and release would be only the second since the start of the war in October 2023. The guarded optimism emerges as U.S. President Joe Biden's national security adviser Jake Sullivan heads to Israel for talks with Prime Minister Benjamin Netanyahu on Thursday and then to Egypt and Qatar, co-mediators with the U.S. on a deal. Separately, President-elect Donald Trump has demanded that militants of the Palestinian Hamas group release the hostages held in Gaza before he takes over from Biden on Jan. 20. Otherwise, Trump has said, there will be “hell to pay.” Trump's designated hostage envoy Adam Boehler has said he too is involved, having spoken already to Biden and to Netanyahu. Israel says 100 hostages remain captive in Gaza. Seven are believed to be U.S. citizens. Citing Trump's threat of "hell to pay," Boehler told Israel's Channel 13 news last week: "I would appeal to those people that have taken hostages: Make your best deal now. Make it now because every day that passes, it is going to get harder and harder and more Hamas lives will be lost." Although Biden and Trump are working separately, their efforts overlap and both stand to gain from a deal. A U.S. official said Trump's public statements about the need for a swift ceasefire “have not been harmful.” The official said the priority is to get the hostages home, whether it is at the end of the Biden term or the start of the Trump term. Steve Witkoff, Trump's designated Middle East envoy, met separately in late November with Netanyahu and Qatar's Prime Minister Sheikh Mohammed bin Abdulrahman Al Thani, said a source briefed on the talks. TIMING IS APT FOR NETANYAHU The timing for a deal may never have been better politically for Netanyahu. The prime minister told reporters on Monday that Hamas' increasing isolation following the collapse of Syrian President Hafez al-Assad's rule opened the door to a possible hostage deal even if it was too early to claim success. Israel's military chief and the head of the Shin Bet internal security service were in Cairo on Tuesday to discuss post-war Gaza border crossings and administration, according to three Israeli security sources. The public optimism of Israeli leaders over the past week has matched the general tone in internal discussions behind closed doors, according to an Israeli official. For Netanyahu, concessions would be far easier now with Israel having reestablished its reputation as the most powerful Middle East force and its Iran-backed enemies in Gaza, Lebanon and Syria now posing less of a threat. Netanyahu's once-fragile coalition has been strengthened by the addition of Foreign Minister Gideon Saar and his more centrist faction. Netanyahu, having achieved a ceasefire with Hezbollah in Lebanon, can complete the picture with the return of the hostages in a deal with Hamas. Over the past year, some of the far-right ministers in his cabinet had voiced objections, even threatening to bring down the government, should the war in Gaza end. But with Israel's enemies weakened, and his coalition strengthened, Netanyahu is far less vulnerable politically. Saar said on Monday that Israel was now more optimistic about a possible hostage deal amid reports Hamas had asked other Gaza factions to help it compile a list of Israeli and foreign hostages in their custody, whether dead or alive. A Palestinian official close to the talks and familiar with the positions of all the parties involved described what he called "a fever of negotiations" with ideas emerging on all sides, including among mediators in Egypt and Qatar. Trump's involvement had given the talks a boost, even if the sides have yet to present lists of Palestinian prisoners and hostages to be exchanged or to complete plans for a temporary or phased truce, the Palestinian official said. He said Hamas was willing to show some flexibility should there be guarantees Israel would not resume the fighting. It is unclear how the sides can bridge the largest gap that has persisted through numerous rounds of failed negotiations; Hamas demands an end to the war, while Israel says the war will not end before Hamas no longer rules Gaza. U.S. Secretary of State Antony Blinken headed to Jordan and Turkey on Wednesday for talks on Syria, the State Department said. Israel is not in his official itinerary but there is always a possibility he might add the stop. (Reporting by Maayan Lubell in Jerusalem and Nidal al-Mughrabi in Cairo; Additional reporting by Steve Holland, Andrew Mills and Humeyra Pamuk; Writing by Howard Goller; Editing by Daniel Wallis)